A
AskBio
Biotechnology company engaged in the development and delivery of novel protein
At a glance
- Founded
- 2001
- Headquarters
- Durham, United States
- Sector
- Biotech & Life Sciences
- Outcome tier
- Unicorn$1–10B valuation tier
Knowledge graph
News
More headlines
Open roles
AskBio in the Durham ecosystem
The AskBio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
- UHUniversity of North Carolina at Chapel Hill
- VVVida Ventures
TPG
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
41 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where AskBio was the backer or acquirer, 2019–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across AskBio's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Where AskBio deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
AskBio's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about AskBio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AskBio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


